Renal artery stenosis: Screening, diagnostic and therapeutic options;Nierenarterienstenose: Screening, diagnostik und therapiemöglichkeiten

Ultraschall in der Medizin

Volumn 21, Issue 6, 2000, Pages 233-244

  Restrepo Schaefer, I ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Diagnosis; Renal artery stenosis; Review; Screening; Ultrasound Doppler studies

Indexed keywords

CAPTOPRIL; CYSTEINE ETHYL ESTER TC 99M; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PENTETATE TECHNETIUM TC 99M;

COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FIBROMUSCULAR DYSPLASIA; HUMAN; IMPLANTATION; INTERVENTIONAL RADIOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY SCINTISCANNING; MAGNETIC RESONANCE ANGIOGRAPHY; RENOVASCULAR HYPERTENSION; REVIEW; SCREENING TEST; STENT; ULTRASOUND; ECHOGRAPHY; HYPERTENSION; PATHOPHYSIOLOGY; REPRODUCIBILITY;

HUMANS; HYPERTENSION; RENAL ARTERY OBSTRUCTION; REPRODUCIBILITY OF RESULTS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0034351880     PISSN: 01724614     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9122     Document Type: Review

References (134)

1. Final Report. Detection, evaluation, and treatment of renovascular hypertension
2. The utility of Duplex Ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis
3. Renovascular hypertension. New diagnostic and therapeutic procedures
4. Ischemic renal diseases have become the most frequent causes of end stage, renal disease in the elderly
5. Ischemic renal disease: An emerging cause of chronic renal failure and end-stage renal disease
6. Ischemic nephropathy: Diagnosis and treatment
7. Ischaemic nephropathy - Is the diagnosis excluded by heavy proteinuria?
8. Diagnostic imaging evaluation of renovascular hypertension
9. Screening for renovascular hypertension in a population with relatively low prevalence
10. Noninvasive diagnosis of renovascular disease
11. Screening for renal artery stenosis: Are scans more accurate than clinical criteria
12. Comparison of two noninvasive screening tests for renovascular hypertension
13. Value of captopril renal scintigraphy in hypertensive patients with renal failure
14. Non-invasive assessment of renal artery stenosis: Current concepts and future directions in magnetic resonance angiography
15. ABC of arterial and venous disease. Renal artery stenosis
16. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement
17. The oldest reported patient with fibromuscular dysplasia of the renal artery
18. Natural history of atherosclerotic and fibrous renal artery disease: Clinical implications
19. Discrepancy of clinical and angiographic results in the follow-up of percutaneous transluminal renal angioplasty (PTRA)
20. Patency of percutaneous transluminal renal angioplasty: A prospective sonographic study
21. Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis
22. Atherosclerotic nephropathy
23. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: Clinico-pathological correlations
24. Vascular mechanisms of renal fibrosis. Vasculo nephropathies and arterial hypertension
25. Prevalence of angiographic atherosclerotic renal artery disease and its relationship to the anatomical extent of peripheral vascular atherosclerosis
26. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere
27. Prevalence of renal artery stenosis in patients with peripheral vascular disease and hypertension
28. Progression of renal artery stenosis in patients undergoing cardiac catheterization
29. Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterization
30. Outcomes of atherosclerotic renal artery stenosis managed without revascularization
31. High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis
32. Renal artery stenosis and chronic renal failure in NIDDM
33. A clinical prediction rule for renal artery stenosis
34. Obstructive lesions of the renal arteries: Etiology and prevalence
35. Fibromuscular dysplasia of the renal arteries: Comparison of helical CT, angiography and arteriography
36. Prospective study of atherosclerotic disease progression in the renal artery
37. Fibromuscular disease of the renal arteries
38. Renal arterial disease and hypertension
39. Possible familial origin of multifocal renal artery fibromuscular dysplasia
40. Fibromuscular dysplasia of the renal arteries
41. The long-term results on arterial pressure and kidney function after the percutaneous transluminal dilatation of renal artery stenosis
42. Predictors of cure of hypertension in fibromuscular renovascular disease
43. Results and complications of angioplasty in fibromuscular disease
44. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease
45. Captopril renography in the diagnosis of renal artery stenosis: Accuracy and limitations
46. Captopril-enhanced scintigraphy using the method of the expected renogram: Improved detection of patients with renin-dependent hypertension due to functionally significant renal artery stenosis
47. Renal scintigraphy with captopril in the evaluation of renovascular hypertension
48. Value of captopril renal scintigraphy in hypertensive patients with renal failure
49. Predicting the outcome of invasive treatment of renal artery disease
50. Aspirin renography and captopril renography in the diagnosis of renal artery stenosis
51. 99mTc-DTPA acetylsalicylic acid (aspirin) renography in the detection of renovascular hypertension
52. A case of renal artery stenosis after transplantation: Can losartan be more accurate than captopril renography
53. Comparison of two noninvasive screening tests for renovascular hypertension
54. Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning
55. Captopril renography and duplex Doppler sonography in the diagnosis of renovascular hypertension
56. Evaluation of duplex ultrasound and captopril renography for detection of renovascular hypertension
57. Doppler ultrasound scanning in the detection of renal artery stenosis in hypertensive patients
58. Using Doppler sonography to reveal renal artery stenosis: An evaluation of optimal imaging parameters
59. Diagnostik und Darstellung von Stenosen der Arteria renalis mittels Farbkodierter Dopplersonographie
60. Diagnosis of renal artery stenosis and renovascular hypertension
61. Value of Doppler ultrasound for the diagnosis of renal artery stenosis in children
62. Accessory renal arteries in human fetuses
63. Renal arteries: Anatomic study for surgical and radiological practice
64. Diagnosis of renal artery stenosis and renovascular hypertension
65. Non-invasive screening for renal artery stenosis with ultrasound contrast enhancement
66. Noninvasive assessment of renal artery stenosis: Current imaging protocols and future directions in ultrasonography
67. Die Darstellbarkeit der Nierenarterien und Wertigkeit der farbkodierten Duplexsonographie der Nierenarterienstenosen unter Verwendung eines Ultraschall-Signalverstärkers
68. Duplexsonographie der Nierenarterienstenose: Möglichkeiten und Grenzen der Frequenzspektrumanalyse der Segmentarterien im Vergleich zur Angiographie
69. Renal hilar Doppler analysis is of value in the management of patients with renovascular disease
70. Renal artery stenosis: Evaluation with colour duplex ultrasonography
71. Renal artery stenosis: Grading with image-directed Doppler US evaluation of renal resistive index
72. Renovaskuläre resistance bei arterieller hypertonie
73. Age-dependency of intrarenal Resistance Index (RI) in patients with essential hypertension
74. Semiquantitative analysen intrarenaler arterieller Dopplerflussspektren bei gesunden erwachsenen
75. Aorteninsuffizienz - Ein möglicher fallstrick bei der analyse renaler Dopplerflussspektren
76. Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease: Correlation of resistive index with biopsy findings
77. Diabetic nephropathy: Evaluation with renal duplex Doppler US
78. Comparison of Doppler US and CT angiography for evaluation of renal artery stenosis
79. Intrarenal Doppler waveform analysis as a screening test for renal artery stenosis
80. Renal artery stenosis: Changes in intrarenal Doppler waveform following percutaneous transluminal angioplasty
81. Prognostic significance of intrarenal resistance indices in patients with renal artery interventions: A preliminary duplex sonographic study
82. Can intrarenal duplex waveform analysis predict successful renal artery revascularization?
83. Objektiver verlaufsparameter nach perkutaner angioplastie (PTA) einer hämodynamisch wirksamen Nierenarterienstenose
84. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent
85. Diagnosis of renovascular disease by extra- and intrarenal Doppler parameters
86. Vergleich der flussprofile in niere und milz als dopplersonographisches kriterium der nierenarterienstenose
87. Intrarenal color Doppler ultrasound for exclusion of renal artery stenosis in cases of multiple renal arteries. Analysis of the Doppler spectrum and tardus parvus phenomenon
88. Stenosis of the accessory renal artery: Doppler ultrasound findings
89. Color Doppler sonographic appearance of renal perforating vessels in subjects with normal and impaired renal function
90. Renal duplex sonography: Main renal artery versus hilar analysis
91. Inter-observer variability in the angiographic assessment of renal artery stenosis. DRASTIC study group. Dutch Renal Artery Stenosis Intervention Cooperative
92. Nephrotoxicity of high osmolality versus low osmolality contrast media: Randomized clinical trial
93. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
94. Effects of saline, manitol, and furosemide on acute decreases in renal function induced by radiocontrast agents
95. Radiocontrast associated renal dysfunction
96. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E
97. Contrast-media-induced nephrotoxicity: A consensus report
98. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors
99. Pathophysiology of radiocontrast nephropathy: A role for medullary hypoxia
100. Protocols and future directions in imaging of renal artery stenosis: CT angiography
101. Characterization of renal artery stenoses based on magnetic resonance renal flow and volume measurements
102. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features
103. Impact of screening MR angiography on referrals for percutaneous intervention in renovascular disease
104. Evaluation of dynamic gadolinium-enhanced breath-hold MR angiography in the diagnosis of renal artery stenosis
105. Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease
106. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis
107. Accuracy of normal-dose contrast-enhanced MR angiography in assessing renal artery stenosis and accessory renal arteries
108. Imaging of renovascular hypertension: Respective values of renal scintigraphy, renal Doppler US, and MR angiography
109. Renal artery stent placement: Utility in lesions difficult to treat with balloon angioplasty
110. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty
111. Renal artery stent placement for the management of ischemic nephropathy
112. Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease
113. Effect of renal-artery stenting on progression of renovascular renal failure
114. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension
115. Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease
116. Renal artery stent placement for the management of ischemic nephropathy
117. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis
118. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group
119. The role of hypertension, obesity, and diabetes in causing renal vascular disease
120. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis
121. Renal artery angioplasty for renovascular hypertension and preservation of renal function: Long-term angiographic and clinical follow-up
122. Nierenarterienstenosen: Dopplersonographische verlaufskontrolle nach PTRA
123. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: An overview of published series
124. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial
125. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: Midterm technical and clinical results
126. MR angiography after renal revascularization: Spectrum of expectedanatomic results and postintervention complications
127. Arterial spasm during renal angioplasty
128. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease
129. Renovascular arterial hypertension. From physiopathology to therapy
130. Prophylactic repair of renal artery stenosis is not justified in patients who require infrarenal aortic reconstruction
131. Renal artery fibromuscular dysplasia: Results of current surgical therapy
132. Atheroembolic renal disease: Effect on morbidity and survival after revascularisation for atherosclerotic renal artery stenosis
133. Chronic renal artery occlusion: Nephrectomy versus revascularization